Phenobarbital-responsive DNA elements were identified in the 5'-flanking region of the chicken CYP2H1 gene by in reporter gene assays in a chicken hepatoma cell line (LMH). A 264 bp enhancer sequence (PBRU) responded to phenobarbital and a variety phenobarbitaltype inducers. Analysis of putative transcription factor binding sites within the 264 bp element revealed a nuclear receptor half-site repeat (DR-4) neighboring a putative nuclear factor-1 site. This motif resembles phenobarbital response elements in the flanking regions of three phenobarbital-inducible genes, rat CYP2B2, mouse Cyp2b10 and human CYP2B6.
Introduction:
The cytochrome P-450 (CYP) 1 gene superfamily encodes proteins responsible for the metabolism of numerous xenobiotic and endobiotic substrates (1) . In addition, the transcription of drug-metabolizing enzymes from CYP1, CYP2 and CYP3 families can be induced a variety of compounds including substrates of these CYPs (2-7). Five different classes of prototypical inducer-drugs that activate distinct but overlapping classes of CYPs have been defined. For example, phenobarbital (PB) induces predominantly enzymes from the CYP2B, 2C and 3A subfamilies (2, 5, 7) . These CYPs, as well as more than 50 other genes, are affected by PB and a number of structurally unrelated compounds classified as PBlike inducers (8) . PB-induction is observed in a wide variety of species ranging from Bacillus megaterium (9) to human. In vertebrates, drug-induction occurs predominantly in the liver and the intestine and to a lesser extent in other extrahepatic tissues such as skin, kidney, lung and brain (2, 5) .
Phosphorylation and dephosphorylation events, cytokines and hormones affect enzyme induction by as yet unknown mechanisms (for review, see 10). Until recently, little was known about the molecular mechanisms of PB-type induction and a receptor for these drugs remains elusive. A major breakthrough has been the recent observation in several laboratories that orphan nuclear receptors are involved in CYP regulation (for review, see ref. 6, 11, 12) .
These findings emerged from the discovery and analysis of well defined PB-responsive elements in the flanking region of rat CYP2B2 and CYP3A1 (13) (14) (15) (16) , mouse Cyp2b10 (17, 18) and human CYP2B6 and CYP3A4 (19, 20) . In particular, the "pregnane X receptor"
(PXR) is involved in the induction of CYP3As (21, 22) and the "constitutive androstane -Page 5 of 31
receptor" (CAR) mediates induction of CYP2Bs (19, 23) . There is considerable overlap between the PXR and the CAR systems in regard to inducers and genes affected.
In chicken liver, CYP2H1 and CYP2H2 are major PB-inducible enzymes (24) . The 5'-flanking region of CYP2H1 has been analyzed by Hahn, Hansen and May and a 4.8 kb PBresponsive enhancer fragment (-5898/-1057) was identified (25) . Within this large DNA region, a small enhancer element of 240 bp was isolated (26) . DNaseI footprinting, gel shift assays and mutational analysis of the 240 bp responsive element suggests that proteins binding to this element are different from the rodent Cyp2b10 responsive element and
consequently, that induction mechanisms may be different in chicken and mammals (26) . A limiting factor in these studies was that the 240 bp fragment mediated only a small response to PB in primary hepatocyte cultures when compared to activation of transcription in vivo (26) .
In the present study, we have analyzed the 5'-flanking region of CYP2H1 by reporter gene assays in the hepatoma cell line LMH that uniquely maintains a pleiotropic response to PB.
We identified a 264 bp enhancer element which overlaps with the 240 bp element of Dogra et al. (26) and discovered a conserved nuclear receptor consensus sequence which mediates PB induction. This motif is also present in PB-inducible genes in mammals. Evolutionary conservation of this element was further supported by trans-species activation of a mouse Cyp2b10 PB-responsive enhancer module in LMH cells. Our results thus indicate that the proteins involved in the activation of the CYP2H1 264 bp PB-responsive element are identical or similar to proteins binding to the mouse and rat PB-responsive enhancer sequences. These findings document the experimental potential of the LMH-hepatoma cell line for PB-induction studies.
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Materials and Methods:
Reagents: Okadaic acid sodium salt and 1-nor-okadaone were purchased from Alexis Biochemicals, Läufelfingen, Switzerland. Dexamethasone, 2-methyl-1,2-di-3-pyridyl-1-propanone (metyrapone), 5-pregnen-3-ol-20-one-16-carbonitrile (PCN) and rifampicin were obtained from Sigma, Buchs, Switzerland. Propylisopropylacetamide (PIA) was generously provided by Peter Sinclair, VA Hospital, White River Junction, Vt, USA.
Glutethimide and -naphtoflavone were purchased from Aldrich, Buchs, Switzerland. The proximal 1.1 kb of the flanking region were amplified by PCR using the primers 5' ACT GAG TTG TGT TTT GGG TCC 3' and 5' GGT GGG CAG AGG AAG AGA TGT 3'. The amplified product was then cut at the 5' end with BamHI and ligated into a pBLCAT6 vector lacking the thymidine kinase-promoter. This vector was prepared by digestion with XhoI vector. For both the Cyp2b10 and the Cyp2b9 51 bp fragments, two copies were ligated head to tail into the reporter vector and these constructs were used in all experiments. All constructs were verified by sequencing.
Analysis of Reporter Gene Expression. 16 hours after drug treatment, the cells were harvested and non-radioactive chloramphenicol acetyltransferase (CAT) assays were performed using the CAT-ELISA kit according to the manual of the supplier (Boehringer Mannheim, Rotkreuz, Switzerland). Cell extracts were also used for the determination of protein concentration using the ESL protein assay for normalization of specific CAT expression to total protein content (Boehringer Mannheim, Rotkreuz, Switzerland). 
Results:
We sequenced 5.9 kb of 5'-flanking region and used this sequence for further isolation and analyses of PB-responsive elements (Fig. 1A) . The subfragments derived from a previously reported 4.8 kb enhancer element (25) The 264 bp PBRU from chicken CYP2H1 was transfected into LMH cells and reporter gene assays were performed after applying different inducers for 16 hours. In parallel, the mouse 51 bp PBREM from Cyp2b10 and its non-inducible mutated counterpart from Cyp2b9 (28) were transfected into LMH cells as a trans-species comparison. We used PB (400 M) and the prototypical PB-like inducers propylisopropylacetamide (PIA) (250 M) and glutethimide (500 M) all of which have predominant effects on CYP2B genes. Further, dexamethasone (50 M), and metyrapone (400 M), two common CYP3A inducers, and the prototypical -Page 12 of 31 CYP1A1 inducer-naphtoflavone (10 M) were also tested. In addition, we were interested in the effects of 5-pregnen-3-ol-20-one-16-carbonitrile (PCN) (50 M) and rifampicin (100 M) due to their species-specific effects on CYP3As. The mouse PBREM from Cyp2b10 was inducible in the chicken LMH cell line whereas the analogous Cyp2b9 51 bp fragment was not inducible (Fig. 2) . Those findings are in agreement with previous reports for mouse primary hepatocytes (18, 28) . Moreover, the spectrum of inducers activating the chicken 264 bp PB-responsive unit (PBRU) closely matched the pattern of the 51 bp Cyp2b10 PBREM (Fig. 2) . The CYP2H1 PBRU was 12 fold induced by PB and whereas 22 other to form a repeat typical for nuclear receptor binding sites. However, two additional sites at -1637/-1632 and -1627/-1622 form a direct repeat with a spacing of four nucleotides (DR-4) on the complementary strand (Fig. 3) . The 5' hexamer constitutes a canonical nuclear halfsite (AGTTCA) while the 3' hexamer forms an imperfect halfsite (AGGGCA).
This DR-4 element was found directly upstream of the putative NF-1 binding site forming a structure that is similar to the ones in rat CYP2B1/2, mouse Cyp2b10 and human CYP2B6 PB-responsive elements (Fig. 4A) . Sequence comparison of the PB-responsive fragments of CYP2H1, Cyp2b10 (28), CYP2B2 (13, 14) , CYP2B6 (19) and Cyp2b9 (28) hexamer halfsite (AGGGCA to GGTATC, denominated "RARc"), the double knock-out of both halfsites (denominated "double") and mutation of the more proximal halfsite into a canonical hexamer halfsite (AGGGCA to AGTTCA, denominated "perfect") were performed by PCR (Fig. 5A ). Mutagenized fragments were cloned into the pBLCAT5 reporter vector -Page 15 of 31 and these constructs were transfected into LMH cells. Inducibility was measured after treating the cells for 16 hours with 400 M PB. Mutation of either halfsite alone or both together eliminated PB-induction of the 264 bp PBRU (Fig. 5B) . When the more proximal halfsite was mutated into a canonical hexamer halfsite, 3 fold induction was observed but at a reduced level when compared to the 5 fold induction detected in the wildtype construct.
These findings are similar to those reported for the Cyp2b10 PBREM in mouse primary hepatocytes (23) . Thus, the DR-4 element found within the 264 bp PBRU plays a major role in mediating PB-induction of this enhancer element.
Protein phosphorylation and dephosphorylation has a major effect on PB-induction (for CYP2H1 mRNA levels 15 fold whereas the negative analog 1-nor-okadaone had no effect (Fig. 6 ). The extent of induction by OA was in general lower than induction of CYP2H1 mRNA by PB that triggered a 25 fold increase. When adding PB to OA-treated cells, no additive effect on transcript levels were observed and a 17 fold induction was obtained. PBRU is more distant from the NR-1 site and on the opposite strand compared to the rat and mouse elements. Moreover, the 5' part of the bipartite NF-1 motif is not a canonical one in the chicken. Nevertheless, the chicken putative NF-1 site is more closely related to the NF-1 consensus than the putative NF-1 site on the human CYP2B6 51 bp PBREM (see Fig. 4B) and comparison of the chicken sequence to the Transfac matrix for NF-1 reveals high conservation. Mutational analysis of the NF-1 site in vitro in reporter gene assays reduced PB-inducibility of the mouse 51 bp PBREM (23) whereas mutations of the NF-1 site of the rat PBRU in transgenic mice had no effect on inducibility (43) . Therefore, the role of the NF-1 site in PB-induction remains unclear. In the mouse 51 bp PBREM, the NR-1 site has been shown to be sufficient for mediating PB-induction (23) . Therefore, the lack of a clear NR-2 site in the chicken 264 bp PBRU may be of no consequence. A more in-depth analysis of the different putative binding sites is currently being attempted. However, down-regulation of genes like the glucose-induced transcription of the S14 gene by OA has also been observed (48) . Moreover, OA has been reported to increase the PBinducible phase II enzyme UDP-glucoronosyl transferase in rat (40) . Thus OA exhibits a variety of gene-specific effects on transcription by influencing protein interaction with different regulatory elements. In this study, we show that OA predominantly activates transcription via the proximal promoter of CYP2H1 and blocks PB induction at the level of the PBRU. These findings explain why CYP2H1 mRNA is induced by OA to a certain level and that this OA-induction is not changed when adding PB. Our results may explain why in the rat OA inhibits CYP2B1/2 mRNA induction by PB but induces a CYP2B1/2 minigene containing the proximal sequence of the 5'-flanking region in reporter gene assays (39, 49) .
The similarity of these data with the inhibition of the transfer of CAR to the nucleus in mouse liver suggests that a CAR-like receptor protein is involved in induction mediated by the 264 bp PBRU in the CYP2H1 5'-flanking region of the chicken.
In spite of its considerable activation by PB, it is suspected that the PBRU described here 
